By studying tumor biology at the molecular level, researchers are gaining a deeper understanding of drug resistance and how to avoid it by designing pediatric cancer treatments tailored to specific mutations in a child's DNA. In a fruitful collaboration, pediatric oncologists and biochemists are targeting neuroblastoma, an often-deadly childhood cancer of the peripheral nervous system...
No comments:
Post a Comment